Aspo Plc Stock exchange release 18 September 2025 at 15.00 EEST Aspo provides restated financial information for 2024 and the first half of 2025 to reflect the divestment of Leipurin Aspo announced in August 2025 the divestment of Leipurin business to Lantmännen. The transaction is subject to regulatory approvals and is expected to be completed in the first quarter of 2026. The divestment will lead to changes in Aspo’s reporting structure. Leipurin has previously formed one of Aspo Group's reportable segmen ...